To address these limitations, future research should focus on conducting well-designed clinical randomized controlled studies with larger sample sizes that encompass diverse racial backgrounds to provide more robust and comprehensive insights into the relationship between B7-H3 expression and bladder cancer. This evidence concerns the gene CD276 and urinary bladder carcinoma.